"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
(Generic versions may still be available.)
Vira-A Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Vira-A (vidarabine monohydrate) Ophthalmic Ointment is an antiviral medication used to treat eye infections caused by the herpes virus. The brand name of this medication is discontinued, but generic versions may be available. Common side effects include burning, stinging, pain, irritation, itching, redness, blurred vision, tearing, or sensitivity to light.
Administer approximately one-half inch of Vira-A Ophthalmic Ointment, 3%, into the lower conjunctival sac five times daily at three-hour intervals. Vira-A may interact with other eye medications. Tell your doctor all medications and supplements you use. It is unknown if Vira-A ophthalmic will harm a fetus. Tell your doctor if you are pregnant. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our Vira-A (vidarabine monohydrate) Ophthalmic Ointment Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Vira-A FDA Prescribing Information: Side Effects
Lacrimation, foreign body sensation, conjunctival injection, burning, irritation, superficial punctate keratitis, pain, photophobia, punctal occlusion, and sensitivity have been reported with VIRA-A (vidarabine) Ophthalmic Ointment, 3%. The following have also been reported but appear disease-related: uveitis, stromal edema, secondary glaucoma, trophic defects, corneal vascularization, and hyphema.
Read the entire FDA prescribing information for Vira-A (Vidarabine)
Additional Vira-A Information
Report Problems to the Food and Drug Administration
Find out what women really need.